Literature DB >> 10777059

Characterization of cancer cell lines established from two human metastatic breast cancers.

S K Nayak1, S Kakati, S R Harvey, C C Malone, A N Cornforth, R O Dillman.   

Abstract

Cell lines are valuable resources for the study of the malignancy and potential therapy of human breast cancer. A major problem with adapting fresh breast tumor specimens to grow in vitro is contamination by fibroblasts. Previously, we have reported a technique to overcome this problem (Nayak, S. K; Dillman, R. O. Clin. Biotechnol. 3:237-242; 1991). We have recently established two new breast cancer cell lines, HH315 and HH375, that were derived from abdominal and supraclavicular lymph node metastases from two patients. They were characterized by (1) growth kinetics; (2) staining with monoclonal antibodies (MoAbs) to cytokeratin-19, epithelial membrane antigen (EMA), anticarcinoembryonic antigen (CEA), breast cancer antigen 1 (BRST-1), breast cancer antigen 2 (BRST-2), Her2/neu, and p53; (3) expression of domains of urinary plasminogen activator (uPA), neural cell adhesion molecule (NCAM), and haptoglobin (Hp) (Harvey et al., 1997); and (4) karyotypic analysis. Growth kinetic studies showed that doubling times for both lines ranged from 48 to 96 h. These two cell lines were found to have characteristics of the metastatic breast cancer cells. Both lines stained positive with MoAbs to cytokeratin-19 and EMA, thus confirming their epithelial origin. They also strongly reacted with the pan-breast carcinoma MoAbs BRST-1 and BRST-2, and carcinoembryonic CEA MoAb. Both cell lines overexpressed the oncogene proteins Her2/neu and p53. The tumor cells were negative for estrogen and progesterone receptors. HH315 cells were poorly differentiated, whereas the HH375 cells exhibited adenocarcinoma morphology. Both cell lines showed intense cell surface and some cytoplasmic staining for uPA, NCAM, and Hp domains, which is a characteristic of malignant neoplasms (Harvey et al., 1997). The HH375 cell line showed two cell types, of which 60% were hyperdiploids with 60-70 chromosomes and 5-10 marker chromosomes. The remaining cells were polyploid with more than 200 chromosomes. Cell line HH315 consisted of only a polyploid population. These cell lines may be useful in breast cancer research.

Entities:  

Mesh:

Year:  2000        PMID: 10777059     DOI: 10.1290/1071-2690(2000)036<0188:COCCLE>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  13 in total

1.  Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.

Authors:  S R Harvey; S K Nayak; G Markus; M Ouhammouch; J J Hemperly; R O Dillman; D J Doyle
Journal:  Arch Biochem Biophys       Date:  1997-09-15       Impact factor: 4.013

2.  Demonstration of human breast carcinoma cells in cryosections and primary monolayer cultures of surgical biopsies by neotetrazolium reductase cytochemistry.

Authors:  O W Petersen; B van Deurs
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

3.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

4.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types.

Authors:  V Band; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines.

Authors:  D A Bronzert; P Pantazis; H N Antoniades; A Kasid; N Davidson; R B Dickson; M E Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Preservation of defined phenotypic traits in short-term cultured human breast carcinoma derived epithelial cells.

Authors:  O W Petersen; B van Deurs
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

7.  Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.

Authors:  H S Smith; W Zoli; A Volpi; A Hiller; M Lippman; S Swain; B Mayall; C Dollbaum; A J Hackett; D Amadori
Journal:  Cancer Res       Date:  1990-05-15       Impact factor: 12.701

8.  A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.

Authors:  M Nuti; Y A Teramoto; R Mariani-Costantini; P H Hand; D Colcher; J Schlom
Journal:  Int J Cancer       Date:  1982-05-15       Impact factor: 7.396

9.  Response to doxorubicin of cultured normal and cancerous human mammary epithelial cells.

Authors:  H S Smith; M E Lippman; A J Hiller; M R Stampfer; A J Hackett
Journal:  J Natl Cancer Inst       Date:  1985-02       Impact factor: 13.506

Review 10.  The biology of breast cancer at the cellular level.

Authors:  H S Smith; S R Wolman; A J Hackett
Journal:  Biochim Biophys Acta       Date:  1984
View more
  3 in total

Review 1.  Canine mammary tumors as a model for human disease.

Authors:  Somaia M Abdelmegeed; Sulma Mohammed
Journal:  Oncol Lett       Date:  2018-04-02       Impact factor: 2.967

2.  Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.

Authors:  Abdulazeez Salawu; Malee Fernando; David Hughes; Malcolm W R Reed; Penella Woll; Claire Greaves; Chris Day; Meshal Alhajimohammed; Karen Sisley
Journal:  Br J Cancer       Date:  2016-08-25       Impact factor: 7.640

Review 3.  Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.

Authors:  Xiaofeng Dai; Hongye Cheng; Zhonghu Bai; Jia Li
Journal:  J Cancer       Date:  2017-09-12       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.